After a long-term distribution partnership with Somagen Diagnostics, which represented Sebia in the Canadian market for many years, the new Canadian Sebia team is excited to engage with customers directly to provide a world-class service and clinically differentiated innovations. The Sebia Canada team will be dedicated and ready to support laboratories across the country with sales, application specialists and after sales engineers. Sebia Canada will also provide scientific services, technical and clinical education, and a "Knowledge Center" service to daily support and assist laboratories in interpreting Sebia laboratory tests.
Sebia Canada is an important step forward in the development of the global company and is fully supported by its shareholders Caisse de dépôt et placement du Québec, CVC Capital Partners and Téthys Invest.
"Starting our direct operations in Canada will enable Sebia to successfully strengthen its undisputed leadership in multiple myeloma management, to continue its development in the diagnostic and monitoring of diabetes and propose other innovative biomarkers using our core technology." says Jean-Marc CHERMETTE, CEO at Sebia.
About Sebia
Sebia a global specialty diagnostic company that develops, manufactures, and commercializes IVD tests and analyzers dedicated to the in vitro diagnosis of cancer, inflammatory diseases, diabetes, and hemoglobin disorders. Sebia's focus on electrophoresis techniques enables it to maintain a sustained R&D program, providing access to genuine innovations in any lab. Both agarose gel and capillary assays, and their dedicated automation, are designed to be integrated into the same routine workflow; for gel (Assist, Hydrasys 2 Scan) and for capillary electrophoresis (Capillarys 3 family instruments , stand alone or in work cell configuration up to three instruments with tube loader, Minicap Flex Piercing).
Mobile Rapid Response Teams Among Other Measures Recommended to Tackle Regional COVID-19 Flare-ups
TORONTO, Sept. 30, 2020 /CNW/ - As the number of COVID-19 cases continues to spike, the Ontario Medical Association (OMA) is recommending the immediate creation of mobile rapid response teams to quickly identify and contain localized flare-ups.
Today, the OMA released A Prescription for Ontario: Maintaining Vigilance as We Learn to Live with COVID-19, a plan which contains recommendations for both the public and the government. The plan addresses our need to minimize the spread of COVID-19 while also tackling the ongoing backlog of medical services. As we go forward it is important to understand that success is a shared responsibility between government and individuals - everyone has a role to play.
The OMA is urging the government to:
Adopt a strategy to address COVID-19 flare-ups early. This may include local short-term, non-essential closures.
Prepare and deploy mobile rapid response teams so trained personnel can identify and contain COVID-19 flare-ups through clinical support, testing, contact tracing and isolation.
Use pop-up testing to bring COVID-19 assessment capacity to hot spots and vulnerable communities as well as support mobile response teams in those communities.
Identify COVID-19 hospitals in each region to allow non-COVID-19 hospitals to ramp up clinical activity and address clinical backlog.
"Mobile rapid response teams will place skills and equipment where they are most needed, while allowing capacity within the system to address the backlog of patient services and better prepare for the flu season," said OMA President Dr. Samantha Hill. "Ontario doctors are deeply concerned about the dramatic rise in the number of COVID-19 cases and are calling on the government to move quickly to contain the spread of the virus and take a regional approach rather than a province-wide one. Timely, graduated and proportionate responses to localized outbreaks will ensure resources are preserved for where they are most needed, a dimmer-switch instead of a sledgehammer."
Dr. Hill said the pandemic is a fluid and constantly changing situation that will vary by region, population and even individuals. "We should not expect the "new normal" to be a return to our pre-COVID normal; the situation will continuously change as the pandemic evolves and the system responds," she said. "That means all of us must be aware and ready to adapt to changing circumstances, guidance and recommendations."
In addition, the OMA is recommending that individuals:
Get tested if they have COVID-19 symptoms or come into contact with someone who has a confirmed case of COVID-19.
Wear a face covering or mask in all indoor public spaces and outdoor spaces when physical distancing may be difficult.
Continue with proper hygiene practices, including handwashing.
Avoid closed spaces or crowded places.
Download and use the COVID-19 alert app.
Continue to seek care for non-COVID-19 related conditions, including mental health concerns.
Get a flu shot when they become available.
Balance the benefits to your mental, social, developmental, physical, and financial wellbeing against decisions that may put you and/or others at risk.
Create a plan for managing essential needs, should you need to self-isolate.
"Tackling COVID-19 is a shared responsibility between all parts of the system and individuals and we are pleased to release a full plan that addresses all sides," said OMA CEO Allan O'Dette. "As localized outbreaks increase, the role and expertise of regional and local public health officials is more important that ever. Ontario's doctors will continue to work with them and with all stakeholders to protect Ontarians during this pandemic and provide them with the best possible care."
About the OMA
The Ontario Medical Association represents Ontario's 43,000 plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system.
SOURCE Ontario Medical Association
How Drug-Testing Has Changed in the COVID-19 Era
Employment expert discusses drug testing and how employers can monitor substance use among WFH employees
A recent survey revealed that positive drug tests among American employees reached a record high in 2019. But drug testing employees in 2020 will be much different due to the COVID-19 pandemic. How can employers monitor substance abuse among workers when millions of employees are working-from-home?
“We know that alcohol use has skyrocketed during the pandemic, and presumably drug use has as well, although those statistics are harder to track,’ says Rob Wilson, President of Employco USA and an employment trends expert. “Understandably, many employers are concerned about substance use among their workers, especially if it is occurring on the clock. Since so many people are working from home, it can be really hard to know if an employee is abusing drugs or alcohol during work hours, yet by the same token, drug-testing can also feel risky during a time when people are afraid to go to the doctor or health clinic or expose themselves to unnecessary germs.”
So how can employers safely continue drug testing their employees while still respecting the very real dangers of the pandemic?
“Mail-in drug tests are a good option for employers who want to monitor employees without requiring the employee to attend an in-person clinic,” says Wilson. “This may be a good option particularly for employees who are high-risk and very concerned about being exposed to the virus.”
For in-person testing, Wilson suggests having a healthcare professional perform the test on-site at your company location.
“Stagger testing times so that employees are able to practice social distancing and aren’t lining up close to one another,” says Wilson. “Have cleaning staff on hand to keep the bathroom sanitized between uses and help employees feel safe.”
Wilson also advises employers to be vigilant about staying in touch with their WFH employees and ensuring that daily timesheets and duties are monitored in order to keep workers on track.
“Daily conference calls or video calls can help to create a feeling of connection as well as help employees to feel seen and valued by their managers,” says Wilson. “Clear expectations and regular, scheduled contact throughout the week will help employees stay on track and create a sense of normalcy and routine that can be very valuable for mental health and for a company’s bottom line.”
Last, Wilson encourages employers to invest in mental health resources for employees and to normalize self-care as part of company culture.
“We know that 1 in 10 Americans struggle with addiction. It’s a disease that often requires outside assistance and treatment in order for the person to find healing and recovery. Drug testing is just one way that employees can monitor substance abuse, but even better is to add complementary practices like offering therapy or addiction recovery information to employees, as well as incentivizing exercise and other physical health measures.”
Jessica Buchanan, Kidnapping Victim Turned Mental Health Advocate, to Headline Brave B.A.S.H.
Humanitarian aid worker was held captive by Somali Pirates; Accelerated Resolution Therapy relieved her PTSD symptoms
TAMPA (Sept. 30, 2020) – Jessica Buchanan was working as a humanitarian aid worker in Somali when she was kidnapped by pirates and held in the desert for 93 days, subsisting on a single daily meal and suffering through extreme heat and cold.
Eventually, Navy SEALs stormed the compound, freeing Buchanan and killing the bandits who had tormented her. But Buchanan’s ordeal did not end upon her return home. She was plagued by nightmares, anxiety and panic attacks and was diagnosed with post-traumatic stress disorder (PTSD)—symptoms that caused her suffering until she tried an innovative therapy called Accelerated Resolution Therapy (ART).
“I call it surviving survival,” says Buchanan. “In a lot of ways, the past eight years have been harder than the 93 days I was held in captivity. Once a trauma event is over, you start living in a whole different way. Your brain functions differently. The way you see yourself changes. The way you see others changes.”
Buchanan tried many different types of therapy before undergoing ART an evidence-based treatment for PTSD, trauma, anxiety and other mental health issues. ART has been extensively used with both veterans and civilians to reframe troubling memories and relieve the physical and emotional symptoms of trauma.
“ART was life-changing for me,” said Buchanan, who lives in Alexandria, Va. with her husband and children. “It was pretty profound. I moved a lot of blockages I didn’t know I had. I got in touch with my purpose again. I feel like I’ve been carrying around a heavy backpack and I finally got to take it off.
Buchanan will be speaking at Brave B.A.S.H., an annual gala for ART International, a Tampa-based nonprofit devoted to increasing access to ART. ART International has helped thousands of veterans, civilians, first responders and other trauma survivors receive this life-changing treatment. This year’s Brave B.A.S.H. will take place both in-person and virtually on Oct. 24. Tickets for both experiences are available at artherapyinternational.com or by calling (813) 435-1374. The event will be emceed by Rebekah Gregory, a survivor of the Boston Marathon bombing, who has also found relief from her trauma through ART.
In light of the COVID-19 pandemic, Buchanan feels that it is even more urgent to share her story. “We are collectively experiencing a prolonged trauma,” she says. “Peoples’ lives have changed dramatically. But for there is hope for people dealing with trauma. You don’t have to live with these symptoms for the rest of your life.
UK REPORTEDLY HOSTING FIRST COVID-19 HUMAN CHALLENGE TRIALS; MOMENTUM GROWS IN CANADA
A GROWING PETITION, SPONSORED BY MP MARCUS POWLOWSKI, CALLS ON THE GOVERNMENT OF CANADA TO PUBLICLY ANNOUNCE COVID-19 HUMAN CHALLENGE TRIALS
The Financial Times reported on September 23rd that London, UK would host the first COVID-19 human challenge trials in January. In such a trial, healthy volunteers are exposed to a virus under controlled conditions to quickly test vaccines and learn more about the disease, potentially saving tens of thousands of lives.
1,660 Canadians have also volunteered to be deliberately exposed to the coronavirus with 1Day Sooner, an organization that advocates on behalf of these “human challenge trial” volunteers.
Now, over 300 Canadians have signed apublic petition calling on the Government of Canada to “publicly announce a plan for COVID-19 human challenge trials.” The petition is sponsored by MP Marcus Powlowski of Thunder Bay-Rainy River and signed by the below Canadian scientists. This comes after MP Marcus and nearly a dozen other MPs and scientists penned a Toronto Star op-ed on August 24th urging the government to green-light COVID-19 human challenge trials.
Below you can find the pictures, first names, locations, and quotes of signatories of the new petition.
###
To connect with any of the below, or any Canadian human challenge trial volunteers, or a 1Day Sooner team member,please email media@1daysooner.org.
Marcus Powlowski, Member of Parliament for Thunder Bay-Rainy River
“There are few issues more important in the world right now than developing a successful vaccine for COVID-19. Governments globally should seriously consider the use of challenge trials as a way to speed up the vaccine development process and, by doing so, potentially save thousands of lives and billions of dollars in lasting economic damage."
Dr. Anand Kumar, Professor of Medicine, Medical Microbiology and Pharmacology, Sections of Infectious Diseases and Critical Care Medicine, at the University of Manitoba.
Dr. Micheal Silverman, Chair and Chief of Adult Infectious Disease at Western University
Dr. Bill Cameron, Professor of Medicine, Division of Infectious Disease, University of Ottawa at The Ottawa Hospital
Conor Barnes, 1Day Sooner volunteer from Kelowna, Canada.
“Sometimes you should take one for the team, and this is a very big team.”
DECN SIGNS AGREEMENT WITH US-BASED LABORATORY AS TESTING PARTNER FOR GENVIRO! SALIVA SWIFT KIT TESTING FOR ADDITIONAL FDA CE MARK AND RUSSIAN FEDERATION SUBMISSIONS
fda & clia certified laboratory will begin testing of the Genviro! 10.5 Sec. Saliva Swift Kit, with full results expected to be reported to regulators in usa, eu and Russian Federation, and will be included in product package inserts
LOS ANGELES, CA—September 30, 2020 / Decision Diagnostics Corp. (OTC: DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has signed an agreement with a certified US-based testing partner to undertake a feasibility study as well as required testing for FDA EUA and European Union CE Mark certification as well as with the Russian Federation for submission of the Genviro! Covid-19 Saliva Swift Kit. The company expects the lab to report its results to DECN, who will include these results in their upcoming FDA EUA applications in Q4 2020, as well as parallel applications with the EU and Russian Federation, as DECN continues its international efforts to make its detection technology available globally. The international product launch commenced on September 26, 2020 at the pricing previously announced. On that date the company received its first large order.
“Coming on the heels of the announcement of having our first international distributor order in place as of September 26, 2020,I am encouraged that the signing of a testing partner in the US will accelerate our efforts to get the Genviro! Covid-19 testing technology authorized by the FDA and in the US market,” said CEO Keith Berman. “Initially slated to be tested for professional use, once we secure FDA authorization we will make the push for our individual at-home use that requires much the same testing. That is what we and the rest of the world truly want to see. In anticipation of this our instructional videos which we are distributing to the international markets were completed for both professional and at-home individual use. As I have repeatedly stated, the test strip and meter reader testing modality upon which our Covid-19 testing technique is based has been used by diabetics to test themselves worldwide for years, so we have every reason to believe that the GenViro! Saliva Swift Kit will be readily accepted in the professional and individual user testing marketplaces for truly rapid Covid-19 testing anywhere, anytime.”
In addition to the signing of a US testing partner and extensive testing already undertaken in Korea, DECN is going to begin a third round of testing in Korea as a semi-finalist participant for the respected XPRIZE, www.xprize.org. XPRIZE is the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges. It operates in collaboration with OpenCovidScreen, a non-profit founded by scientists and business leaders, to drive needed innovation through “Open Science”. XPRIZE, OpenCovidScreen and a coalition of partners call on the global community to develop frequent, fast-turnaround, reliable, and easy-to-use screening tests to detect Covid-19 occurrences before they become outbreaks. The $5 million XPRIZE Rapid Covid Testing competition is designed to accelerate the development of high-quality Covid-19 testing that is low cost, accurate, easy to use, and provides a fast-turnaround, enabling frequent testing.
To meet the XPRIZE requirements, DECN will be testing samples containing both contrived, non-infected and contrived infected samples supplied by the organization. The samples will be shipped to Korea for testing and the results will be available once the XPRIZE committee announces its winning selection. The organization expects to report finalists in November 2020 and Grand Prize Winners in Q1 2021.
ABOUT DECISION DIAGNOSTICS CORP
Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With newly inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market. The company's new GenViro!™ product designed to test for Covid-19, is not yet available in the United States or Puerto Rico, but Emergency (EUA) Waivers are in process with the U.S. FDA. On September 30, 2020 the company began the launch of its International package versions of its GenViro! Swift Kit and Swift Meter. In addition, the company reports that its international distributor for the Russian Federation will be taking on the Genviro! products, will handle registration for emergency use approval in the Russian Federation, and has requested a non-exclusive agreement or waiver for expansion into the European Union as well.
Forward-Looking Statements:
This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of September 29, 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.
How to Care for Sore Muscle Groups After an Intense Workout
While it is an excellent ritual to develop in your personal routine, intense workouts can wear your muscles down if you don’t learn how to care for your muscles. To maximize the effectiveness of your workouts, make sure you take adequate breaks in between working out specific muscle groups. Also, it’s wise to take good care of sore muscles with the right methods. Consider the following tips to make sure all goes well.
Ice Bath
Many professional athletes use this method as a means of recovery after a major game, match or workout. Start by filling up the bathtub with cold water. Then, add a ton of ice to the mix. Whether you add an entire bag of ice or a few bowls of ice, the ice will take the cold bath to the next level. While it might shock the system at first, an ice bath is known for its ability to reduce inflammation, decrease the pain and improve blood circulation. If you’d prefer to work up to the ice bath, start with ice packs after each workout.
Hot Tub
On the other end of the spectrum, a hot bath can be one of the most beloved rituals for anyone who’s looking to unwind and relax their muscles. The heat can be really effective in improving circulation as well. Consider adding some Epsom salts or other bath salts to maximize the experience. Some companies, like Marquis Spas, know that if you have access to one, using a hot tub after workouts can truly provide a divinely relaxing experience that you’ll look forward to.
Stretches
If you’re not already stretching on a regular basis, chances are your body will become unbelievably tight. This can directly impact the mobility within your joints and limbs. It can also impact how your muscles operate. You’ll expose yourself to a greater chance of injured muscles if you don’t stretch regularly. Whether you set aside 15 or 45 minutes aside, dedicate specified time for stretching your entire body.
Massages
There’s a two-pronged approach to massages. You can start by investing in personal equipment such as massage chairs, foot massagers and more. Massages can improve circulation and provide aid to sore muscles. The second part of your massage approach should involve a professional. Getting a professional massage is one of the best ways to alleviate soreness and experience specialized attention on the areas that are tense.
There are plenty of other methods to consider such as balms, tinctures and heated blankets. As long as you find the right methods and use them consistently, your muscles will recover, grow and develop into the physique you’re longing to uncover.
CrossRoads of Southern Nevada to Begin Holding Addiction Education Sessions
Sessions will be for families suffering through addiction
Please join us, in person with a mask, or virtually, for CrossRoads of Southern Nevada, Nevada’s largest drug and alcohol addiction center, first in a series of education seminars on addiction, focused specifically on family members who may be dealing with addiction.
Millions of opiates are prescribed every year in Nevada with no real plan to get patients off of them. If you or a loved one are suffering from opiate addiction, education on the proper treatment is essential. At the seminar, we’ll cover with Dr Bradley, the proper treatment of opioid use, including:
Methadone, Bupenorphrine, or naltrexone.
We’ll also discuss Narcan, what is it, how it works, and why every family who may be dealing with opiate addiction should have it. It is available without a prescription thanks to the NV Legislature.
Alcohol and other drugs will be addressed. We will review the disease model as well as how the entire family system is impacted and the role they play. Along with medically assisted treatment, multiple therapeutic approaches will be addressed.
These topics will be broken down to easily understandable components and individually addressed over our presentation series.
WHEN: October 3, 2020. 12-2 PM PT.
WHERE: 1120 Shadow Lane
VIRTUALLY: Zoom link will be sent to RSVPs
If you’d like to attend, please RSVP here in email or to Nicole Christie, at 702-382-7746
Dr Joseph Bradley Biography
Dr. Joseph J. Bradley is a Board Certified Addictionologist and Diplomate in Addictionology. He has a master’s degree in substance abuse counseling and education, is a licensed Chiropractic Physician, a Doctoral candidate in Clinical Psychology and has extensive education in Naturopathic Medicine/Science.
Dr. Bradley is a certified interventionist, adjunct professor and published author on addiction. Dr. Bradley has been adjunct faculty for; University of Phoenix, National University, College of Southern Nevada, American College of Addictionology and Compulsive Disorders, Life University and currently John Patrick University.
He has served as Director of Chronic pain program and lead family day facilitator for Solutions Recovery and Desert Hope, Director of physical medicine for Las Vegas Recovery Center, Director of Integrative Medicine for Sober Living by the Sea, Lead family day presenter at Edgefield Recovery as well as consultant for Cirque Lodge. He has presented as keynote speaker at numerous conferences nationally.
He is currently The Vice President of Integrative Medicine at Cross Roads of Southern Nevada and group facilitator at Thrive Solutions Treatment in Las Vegas, NV.
Dr. Bradley in private practice, treats addiction, chronic pain, trauma and other related healthcare issues. As the creator and facilitator of a national destination program, Dr. Bradley has worked with veterans, first responders and other trauma related professions. He helps clients understand the neural biology of how and why they feel, act and react the way they do.
Fitzrovia Real Estate Collaborates with Cleveland Clinic Canada to Provide Virtual Care to Residents
Cleveland Clinic Canada to provide all Fitzrovia properties with on-demand virtual care for its residents through its Express Care ®Online service
TORONTO, Sept. 29, 2020 /CNW/ - Fitzrovia Real Estate Inc. ("Fitzrovia") announced today that Cleveland Clinic, a global healthcare leader, will provide all residents virtual access to world-class healthcare through its Express Care Online® service. Express Care Online is a virtual appointment service that allows individuals to access a Cleveland Clinic Canada clinician for non-emergency medical issues.
Each Fitzrovia property will provide residents access to a designated space in their building where they can receive a private and confidential virtual medical exam using Express Care Online® and TytoClinic™ remote diagnostic tools. All residents over the age of two will be able to be assessed for a variety of medical concerns includes screening for COVID-19.
Fitzrovia Real Estate strives to be a leader in lifestyle programming for residents with healthcare forming a key pillar. With the enhanced requirements surrounding COVID-19, access to virtual care will provide an added layer of comfort to Fitzrovia residents.
"Our strategic collaborations continue to be an important part of our company. At a time when convenient access to quality healthcare is critical to our well-being, we are proud to work with Cleveland Clinic Canada to provide world-class care for our residents. We care deeply about our residents and this complimentary offering illustrates our commitment to their safety and well-being." said Adrian Rocca, CEO, Fitzrovia Real Estate.
The Waverley, Fitzrovia's first purpose-built rental building (located at the northwest corner of Spadina Avenue and College Street to Fitzrovia residents in Toronto), will debut the virtual clinic amenity for residents. The building will be complete in late 2020 and will include 166 upscale suites with 1, 2 and 3-bedroom options.
Fitzrovia's partnership with Cleveland Clinic Canada is the latest in several corporate partnerships where the company is committed to enhancing its resident living experience.
About Fitzrovia Real Estate
Fitzrovia Real Estate Inc. is a vertically integrated developer and asset manager of class-A apartment buildings across select neighborhoods in the Greater Toronto Area. Fitzrovia partners with public institutions, pension plans and high net worth investors who have an investment bias towards long term cash flow generating assets. In addition to focusing on traditional asset management, Fitzrovia focuses on driving income through active lifestyle management and exceptional customer service offering residents unique lifestyle choices that redefine urban living. Our customer-first approach means all design and construction decisions are deeply rooted in consumer insights to ensure our resident needs are not only met but exceeded. We differentiate ourselves through high quality design and innovative amenity programming combined with a strong desire to reimagine the resident experience. This is our competitive advantage. At Fitzrovia we think differently and build differently.
For more information, please visit: fitzroviarealestate.ca, follow @FitzroviaRealEstate on Instagram
SOURCE Fitzrovia Real Estate Inc.
Ocean Platform Joins apps.health Marketplace to Help Connect Patients with Healthcare Providers
TORONTO, Sept. 29, 2020 /CNW/ - The Ocean Platform, Canada's leading EMR-integrated digital health suite for patient engagement, is now available on apps.health, a digital health app marketplace and innovation hub from WELL Health. With this release, CognisantMD is also launching a series of powerful new tools and features for OSCAR Pro Electronic Medical Record (EMR) through its enhanced Cloud Connect API integration.
Over 13,000 healthcare providers across the country use the Ocean Platform to allow Canadians to securely share health information, update their patient record, and connect with their physicians each day. The Ocean library of editable intake forms, consent forms, and patient history tools connects directly to a suite of integrated patient tools, providing an easy way to collect information from patients and conduct eReferrals.
The first version of Ocean for OSCAR EMR was launched in 2015, with a focus on patient forms presented on waiting room tablets and patient forms at home. With the newly released Cloud Connect integration, OSCAR Pro EMR users now have access to a full suite of tools and features including secure patient messages, appointment reminders, check-in kiosks, website forms with patient attachments, patient surveys and seamlessly integrated eReferrals.
"COVID-19 forced physicians to reinvent the way they deliver patient care, virtually overnight. Today, every healthcare provider needs to have access to proven, secure digital health solutions that can support this continually evolving approach to healthcare," said Jeff Kavanagh, President, CognisantMD. "We're pleased to join with other innovative technology providers to address these urgent needs and connect with the healthcare community through the apps.health marketplace."
In addition to Ocean's Tablet, Patient Messages, and Studies product offerings, OSCAR Pro EMR users can now access the following products and features:
Check-In Kiosks - Streamline check-in and enforce social distancing on a kiosk with optional demographic updates, screening, consent forms and more;
Patient Reminders - Schedule automatic reminders about upcoming appointments, conduct patient experience surveys, and automate follow-up messages after appointments;
Patient Authenticated Website Forms - Securely accept photos and attachments from your patients;
Advanced eReferral Capabilities - Launch the Ocean Healthmap from the Consultations window, seamlessly send referrals and upload referral attachments, and allow Ocean to automatically update the consult in OSCAR as the status of the referral changes.
About CognisantMD CognisantMD is the nation's leading provider of EMR-integrated patient engagement and eReferral solutions. The cloud-based platform is used by over 13,000 healthcare providers across Canada to securely connect with patients, share patient health information, and seamlessly update patient records. With a library of thousands of clinical and administrative forms, the Ocean Platform supports the secure exchange of patient data through a full suite of tools including Online Booking, Check-in Kiosks, Patient Tablets, Patient Messages, Patient Reminders, Website Forms, Ocean Studies and eReferrals. To learn more about the Ocean Platform or request a demo, visit cognisantmd.com.
SOURCE CognisantMD
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
